Ocugen, Inc.
NASDAQOcugen heads into its Q1 2026 earnings call today heavily scrutinised by short sellers, with the stock's lending dynamics forming the central narrative for the session. Short interest is the dominant signal here. At 21.2% of free float — up more than 12% over the past month — this is a stock where more than one in five freely tradeable shares has been sold short. Days to cover…
Snapshot as of 7 May 2026
Ocugen heads into its Q1 2026 earnings call today heavily scrutinised by short sellers, with the stock's lending dynamics forming the central narrative for the session. Short interest is the dominant signal here. At…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for OCGN — free to start on ORTEX.
Sign up for free →Open OCGN on ORTEX